David Gandara
MD
Professor of Medicine and Director Emeritus, Thoracic Oncology Program
👥Biography 个人简介
Dr. David Gandara is a pioneer in thoracic oncology and molecular profiling of lung cancer. He has led landmark trials in KRAS-mutant NSCLC and championed the use of biomarker-driven therapy selection. His work on sotorasib in CodeBreaK trials established sotorasib as the first approved KRAS G12C inhibitor. He has contributed extensively to understanding resistance mechanisms in KRAS-mutant lung cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 David Gandara 的研究动态
Follow David Gandara's research updates
留下邮箱，当我们发布与 David Gandara（UC Davis Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment